• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在社区泌尿外科诊所通过细胞学分析和流式细胞术筛查尿路上皮恶性肿瘤:一项前瞻性研究。

Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.

作者信息

Gourlay W, Chan V, Gilks C B

机构信息

Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Mod Pathol. 1995 May;8(4):394-7.

PMID:7567937
Abstract

A prospective study was initiated to compare the ability of flow cytometry and cytologic analysis to detect malignant cells in urine obtained at the time of cystoscopy. The population studied consisted of patients from general urologic practices who were undergoing cystoscopy in a single community hospital. Over a 1-yr period, 335 specimens from 317 patients were studied. Nineteen biopsy-proven urothelial malignancies were identified. Cytologic examination of urine obtained at the time of cystoscopy was positive in seven of these cases, and an aneuploid population of cells was identified by flow cytometry in three cases. All three cases of high-grade transitional cell carcinoma and carcinoma in situ were correctly identified by the combination of cytologic examination and flow cytometry; however, only four of 16 low-grade superficial papillary transitional cell carcinomas were recognized cytologically, with only one being aneuploid. The combination of cytologic analysis and flow cytometry did not increase the diagnostic sensitivity above that achieved with cytologic testing alone (overall sensitivity, 37%). We conclude that flow cytometry and cytologic analysis, either individually or in combination, are too insensitive for use in a routine screening program for urothelial malignancy in a community hospital setting because of the inability of either method to detect low-grade transitional cell carcinomas reliably.

摘要

一项前瞻性研究启动,旨在比较流式细胞术和细胞学分析检测膀胱镜检查时所取尿液中恶性细胞的能力。研究人群包括在一家社区医院接受膀胱镜检查的普通泌尿外科患者。在1年的时间里,对317例患者的335份标本进行了研究。确定了19例经活检证实的尿路上皮恶性肿瘤。膀胱镜检查时所取尿液的细胞学检查在其中7例中呈阳性,流式细胞术在3例中鉴定出非整倍体细胞群。通过细胞学检查和流式细胞术的联合检测,所有3例高级别移行细胞癌和原位癌均被正确识别;然而,16例低级别浅表乳头状移行细胞癌中,细胞学仅识别出4例,其中只有1例为非整倍体。细胞学分析和流式细胞术的联合检测并未使诊断敏感性高于单独进行细胞学检测时的水平(总体敏感性为37%)。我们得出结论,由于两种方法都无法可靠地检测低级别移行细胞癌,因此在社区医院环境中,流式细胞术和细胞学分析单独或联合使用时,对尿路上皮恶性肿瘤的常规筛查程序来说敏感性都太低。

相似文献

1
Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.在社区泌尿外科诊所通过细胞学分析和流式细胞术筛查尿路上皮恶性肿瘤:一项前瞻性研究。
Mod Pathol. 1995 May;8(4):394-7.
2
DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma.尿细胞学的DNA图像分析:复发性移行细胞癌的预测
Mod Pathol. 1996 May;9(5):571-8.
3
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.
4
Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.膀胱镜活检和尿液细胞学检查中尿路上皮细胞和炎性细胞上的环氧化酶-2表达作为膀胱癌的一种可能预测标志物
APMIS. 2009 Jan;117(1):45-52. doi: 10.1111/j.1600-0463.2008.00014.x.
5
Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.1998年世界卫生组织/国际泌尿病理学会分类背景下低级别乳头状尿路上皮肿瘤(低度恶性潜能和低级别癌)的细胞学诊断
Diagn Cytopathol. 2003 Apr;28(4):186-90. doi: 10.1002/dc.10263.
6
Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.对膀胱移行细胞癌患者的脱落尿路上皮细胞进行荧光原位杂交。
Urology. 2004 Feb;63(2):398-401. doi: 10.1016/j.urology.2003.08.026.
7
Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.评估荧光原位杂交作为尿液细胞学辅助工具在诊断尿路上皮癌中的应用。
Diagn Cytopathol. 2003 Jun;28(6):301-7. doi: 10.1002/dc.10291.
8
Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.NMP22在膀胱移行细胞癌管理中的临床应用。
Cancer Detect Prev. 2000;24(4):364-8.
9
Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).用于监测低级别非肌层浸润性尿路上皮癌的排尿样本微卫星分析:一项前瞻性多中心研究(膀胱癌随访成本效益试验[CEFUB])的可行性和临床效用
Eur Urol. 2009 Mar;55(3):659-67. doi: 10.1016/j.eururo.2008.05.001. Epub 2008 May 15.
10
Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.细胞学评估与定量数字细胞术相结合在检测尿路改道患者的复发性疾病方面是可靠的。
Cancer. 2007 Oct 25;111(5):323-9. doi: 10.1002/cncr.22950.